Information2021
- Dec. 23, 2021 IROlympus to Present at J.P. Morgan Healthcare Conference
-
Dec. 17, 2021
IRNotice Concerning Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)
-
Dec. 17, 2021
IRNotice of Absorption-type Merger with Olympus Logitex, a Wholly Owned Subsidiary (Simplified and Short-form Merger)
-
Dec. 17, 2021
IRNotice Regarding Stock Repurchase
- Dec. 07, 2021 IROLYMPUS Investor Day 2021
- Nov. 16, 2021 CorporateUpdate about cybersecurity incident in the U.S. – systems restored
- Nov. 05, 2021 IRSecond Quarter Financial Results
-
Nov. 05, 2021
IR(Progress of Disclosure Matters) Notice Concerning Commencement of Consideration on Intra-Group Reorganization of Scientific Solutions Business
- Oct. 21, 2021 IRUpdate: IR Library "Olympus Medical Business"
- Oct. 19, 2021 CorporateUpdate: Investigation into cybersecurity incident ongoing
- Oct. 12, 2021 CorporateInvestigating potential cybersecurity incident affecting our IT system in the Americas
-
Oct. 01, 2021
IR(Progress of Disclosure Matters) Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
- Sep. 30, 2021 IRPublished Integrated Report 2021
-
Sep. 27, 2021
IRNotice Regarding Establishment of a Corporate Venture Capital Fund “Olympus Innovation Ventures”
- Sep. 24, 2021 CorporateOlympus to be listed the in the “Prime Market” segment on the TSE
-
Sep. 24, 2021
IRNotification with new appointment of the Executive Officers
-
Sep. 24, 2021
IRNotice Regarding Application for Selection of New Market Segment “Prime Market” on the Tokyo Stock Exchange
- Sep. 14, 2021 CorporateUpdate: Olympus Investigation Into Cybersecurity Incident Ongoing
- Sep. 11, 2021 CorporateInvestigating potential cybersecurity incident affecting limited areas of our EMEA IT system
- Aug. 05, 2021 IRFirst Quarter Financial Results
-
Jul. 21, 2021
IRNotice of Completion of Payment for Disposal of Treasury Shares as Post-Delivery Type Restricted Share-Based Compensation
-
Jul. 09, 2021
IRNotice Concerning Dismissal of the Appeal against the Consolidated Subsidiary (Sub-subsidiary)
-
Jun. 24, 2021
IRNotice of Disposal of Treasury Shares as Post-Delivery Type Restricted Share-Based Compensation
-
Jun. 17, 2021
IR(Change of Disclosure Matters) Notice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Jun. 04, 2021
IRNotice Concerning Commencement of Consideration on Intra-Group Reorganization of Scientific Solutions Business
-
May. 28, 2021
IR(Progress of disclosure matters) Notice Regarding Completion of Acquisition of Israeli medical device company Medi-Tate Ltd. (new subsidiary)
- May. 07, 2021 IRFinancial Results
-
May. 07, 2021
IRNotice Regarding Dividend of Retained Earnings
-
May. 07, 2021
IRNotice Regarding Cancellation of Treasury Stock
-
Apr. 30, 2021
IR(Change of Disclosure Matters) Notice Regarding start of the process to acquire Israeli medical device company Medi-Tate Ltd. (new subsidiary) pursuant to its call option rights
-
Apr. 30, 2021
IRNotice Concerning the Revision of Financial Forecast
-
Apr. 09, 2021
IRNotice Concerning Dismissal of the Lawsuit and Filing of Appeal against the Consolidated Subsidiary (Sub-subsidiary)
-
Apr. 06, 2021
IRNotice Concerning Termination of the Consolidated Subsidiary (Sub-subsidiary)’s Interventions in an Administrative Lawsuit
-
Mar. 12, 2021
IRNotice Concerning the Consolidated Subsidiary (Sub-subsidiary)’s Intervention in an Administrative Lawsuit
-
Feb. 26, 2021
IRNotice Regarding start of the process to acquire Israeli medical device company Medi-Tate Ltd. (new subsidiary) pursuant to its call option rights
-
Feb. 26, 2021
IRNotice Regarding Result of the Career Support for External Opportunity
- Feb. 12, 2021 IRThird Quarter Financial Results
-
Feb. 12, 2021
IRNotice Concerning Recording Other Expenses and the Revision of Financial Forecast
-
Feb. 12, 2021
IRNotification for the Candidate for the Board of Directors
-
Feb. 12, 2021
IRNotice Concerning Internal Reorganization of Domestic Sales Functions through Company Split (Simple Absorption-type Split)
-
Feb. 10, 2021
IR(Progress of disclosure matters) Notice regarding completion of acquisition of Quest Photonic Devices B.V. (to make it a subsidiary) in the Netherlands
-
Jan. 28, 2021
IRNotice regarding Acquisition of Quest Photonic Devices B.V. (to make it a subsidiary) in the Netherlands
-
Jan. 04, 2021
IR(Progress of Disclosure Matters) Notice Regarding Closing of Divestiture of Imaging Business